DK0803253T3 - Matrixtabletter indeholdende tianeptin-natriumsalt til oral anvendelse og med forsinket frigivelse - Google Patents

Matrixtabletter indeholdende tianeptin-natriumsalt til oral anvendelse og med forsinket frigivelse

Info

Publication number
DK0803253T3
DK0803253T3 DK97400911T DK97400911T DK0803253T3 DK 0803253 T3 DK0803253 T3 DK 0803253T3 DK 97400911 T DK97400911 T DK 97400911T DK 97400911 T DK97400911 T DK 97400911T DK 0803253 T3 DK0803253 T3 DK 0803253T3
Authority
DK
Denmark
Prior art keywords
sodium salt
delayed release
oral use
tablets containing
matrix tablets
Prior art date
Application number
DK97400911T
Other languages
Danish (da)
English (en)
Inventor
De Barochez Bruno Huet
Patrick Wuthrich
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0803253T3 publication Critical patent/DK0803253T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK97400911T 1996-04-24 1997-04-23 Matrixtabletter indeholdende tianeptin-natriumsalt til oral anvendelse og med forsinket frigivelse DK0803253T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9605174A FR2747921B1 (fr) 1996-04-24 1996-04-24 Comprime matriciel permettant la liberation prolongee du sel de sodium de tianeptine apres administration par voie orale

Publications (1)

Publication Number Publication Date
DK0803253T3 true DK0803253T3 (da) 2001-11-19

Family

ID=9491549

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97400911T DK0803253T3 (da) 1996-04-24 1997-04-23 Matrixtabletter indeholdende tianeptin-natriumsalt til oral anvendelse og med forsinket frigivelse

Country Status (18)

Country Link
US (1) US5888542A (de)
EP (1) EP0803253B1 (de)
JP (1) JPH1036268A (de)
CN (1) CN1116029C (de)
AT (1) ATE205715T1 (de)
AU (1) AU719822B2 (de)
CA (1) CA2203310C (de)
DE (1) DE69706748T2 (de)
DK (1) DK0803253T3 (de)
ES (1) ES2164310T3 (de)
FR (1) FR2747921B1 (de)
GR (1) GR3037043T3 (de)
HU (1) HU224192B1 (de)
NO (1) NO315407B1 (de)
NZ (1) NZ314662A (de)
PL (1) PL188135B1 (de)
PT (1) PT803253E (de)
ZA (1) ZA973495B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2791891A1 (fr) * 1999-04-07 2000-10-13 Adir Utilisation de la tianeptine pour l'obtention de medicaments destines au traitement des pathologies de la neurodegenerescence
US6683072B1 (en) 2003-02-04 2004-01-27 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia
RS51934B (en) * 2003-08-08 2012-02-29 Biovail Laboratories International Srl. BUPROPION HYDROCHLORIDE TABLE WITH MODIFIED RELEASE
US20050227961A1 (en) * 2004-04-08 2005-10-13 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome
US9314469B2 (en) 2008-05-05 2016-04-19 Tonix Pharma Holdings Limited Method for treating neurocognitive dysfunction
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
US8355927B2 (en) 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
US20110237537A1 (en) * 2009-05-29 2011-09-29 Lombard Jay L Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
EP2435586A4 (de) * 2009-05-29 2012-12-26 Genomind Llc Verfahren zur beurteilung und behandlung von depressionen durch verwendung der analyse von einzelnukleotidpolymorphismen
KR20120092993A (ko) * 2011-02-14 2012-08-22 지엘팜텍 주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
EP2561864B1 (de) * 2011-08-25 2014-12-31 Zaklady Farmaceutyczne Polpharma SA Beschichtete Tablette mit Tianeptin und Verfahren zu deren Herstellung
KR101136976B1 (ko) * 2011-09-06 2012-05-30 건일제약 주식회사 티아넵틴 또는 그의 염을 포함하는 탈모증의 예방 또는 치료용 약학 조성물
GB201208315D0 (en) 2012-05-11 2012-06-27 Numedicus Ltd Pharmaceutical methods and compositions
CN104031005B (zh) * 2014-05-30 2016-04-27 济南诚汇双达化工有限公司 一种噻萘普汀钠中间体的制备方法
KR20180101307A (ko) 2018-09-04 2018-09-12 지엘팜텍주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
KR20200104265A (ko) 2020-08-21 2020-09-03 지엘팜텍주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
FR2635461B1 (fr) * 1988-08-18 1992-01-17 Adir Utilisation de derives tricycliques pour l'obtention de medicaments destines au traitement du stress
FR2716623B1 (fr) * 1994-02-25 1996-08-23 Adir Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs.

Also Published As

Publication number Publication date
ATE205715T1 (de) 2001-10-15
PL319627A1 (en) 1997-10-27
NO971860L (no) 1997-10-27
CN1168792A (zh) 1997-12-31
DE69706748D1 (de) 2001-10-25
HUP9700806A3 (en) 2000-01-28
NZ314662A (en) 1998-12-23
AU1904197A (en) 1997-10-30
DE69706748T2 (de) 2002-07-04
ZA973495B (en) 1997-11-18
GR3037043T3 (en) 2002-01-31
PT803253E (pt) 2001-12-28
NO315407B1 (no) 2003-09-01
CN1116029C (zh) 2003-07-30
PL188135B1 (pl) 2004-12-31
EP0803253A1 (de) 1997-10-29
FR2747921A1 (fr) 1997-10-31
HUP9700806A2 (hu) 1998-10-28
ES2164310T3 (es) 2002-02-16
HU224192B1 (hu) 2005-06-28
FR2747921B1 (fr) 1998-10-30
CA2203310A1 (fr) 1997-10-24
JPH1036268A (ja) 1998-02-10
HU9700806D0 (en) 1997-06-30
NO971860D0 (no) 1997-04-23
US5888542A (en) 1999-03-30
AU719822B2 (en) 2000-05-18
CA2203310C (fr) 2001-10-23
EP0803253B1 (de) 2001-09-19

Similar Documents

Publication Publication Date Title
DK0803253T3 (da) Matrixtabletter indeholdende tianeptin-natriumsalt til oral anvendelse og med forsinket frigivelse
IS5190A (is) Lyfjafræðileg blanda N-Píperídínó-3-pýrazólkarboxamíð afleiðum, söltum og lausnarsamböndum til munnlegrar inntöku
DK1375503T3 (da) Dioxinoderivater og deres anvendelse som dopaminagonister
ATE200864T1 (de) Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
DK0656776T3 (da) Flerlagstabletter med reguleret frigivelse indeholdende både naproxen og naproxen-natriumsalt
DK1174135T3 (da) Farmaceutisk sammensætning omfattende pioglitazon og glimepirid til anvendelse i behandling af diabetes
NO974808L (no) Styrt frigivelse av legemidler for miose og mydriase i fremre kammer
NO20065390L (no) Farmasoytisk preparat i fast enhetsdoseringsform
DK0734260T3 (da) Paroxetintabletter og fremgangsmåde til fremstilling deraf
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
DE69625189D1 (de) Tablette mit gesteuerter freisetzung
DE69327745T2 (de) Tablette zur langsamen Freisetzung von Natriumvalproat
NZ504418A (en) Delayed release oral dosage form of carvedilol
IS4212A (is) Aðferð til framleiðslu á N-metýl-3-(1-metýl-4-píperidinýl)-1H-indól-5- etansúlfonamíð og lífeðlisfræðilega viðunandi söltum þess og lausnum þeirra
NO922385D0 (no) Mykt toerrfor, saerlig til bruk som avvenningsfor, og fremgangsmaate til fremstilling derav
NO20002962D0 (no) FremgangsmÕte for fremstilling av fludarabinfosfatlium-, - natrium-, -kalium-, -kalsium- og -magnesiumsalter, fremgangsmÕte for rensing av fludarabinfosfat, og fludarabinfosfat som er minst 99,5% rent
NO984035D0 (no) Farmas°ytiske formuleringer med sakte frigivelse inneholdende mizolastin
ES532645A0 (es) Una tableta farmaceutica de liberacion controlada
DE69725166D1 (de) Substituierte benzamidderivate und diese enthaltende pharmazeutische zusammensetzung
DK655989A (da) Mikrokapsler til lindring af tandsygdomme og indeholdende et terapeutisk middel
DK469087D0 (da) Farmaceutisk praeparat indeholdende et calciumoptagelsesblokerende middel og en ace-inhibitor.
DE69702125T2 (de) Implantat zum einzementieren in knochen
HUP0002459A3 (en) Salts of optically active sulfoxide derivative, pharmaceutical compositions containing them and use thereof
FR2752737B1 (fr) Comprime a liberation controlee de chlorhydrate d'alfuzosine
AU4580897A (en) Screw implant for intermaxillary fixation of partially edentulous jaw